SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-179105
Filing Date
2010-08-05
Accepted
2010-08-05 14:40:58
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 552148
2 PURCHASE AGREEMENT dex101.htm EX-10.1 114472
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 6610
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 7339
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - SECTION 906 dex321.htm EX-32.1 4168
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SECTION 906 dex322.htm EX-32.2 4170
  Complete submission text file 0001193125-10-179105.txt   690320
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 10993950
SIC: 2834 Pharmaceutical Preparations